Skip to main content
. 2025 Apr 11;16:1574679. doi: 10.3389/fphar.2025.1574679

TABLE 3.

Serum iPTH Relative to Baseline After 12 Weeks of Treatment in three groups.

Group Baseline Week 12 χ 2 P value
Mild Group (n = 20) 463.15 (429.00,528.70) 178.70 (146.28,282.83) 47.421 <0.001
Moderate Group (n = 12) 706.75 (673.48,733.93)a 316.40 (231.55,360.93)a 37.571 <0.001
Severe Group (n = 12) 952.15 (870.28,1158.25)a,b 419.20 (221.33,695.38)a 33.536 <0.001

Note: Compared with the mild group, a P < 0.05; compared with the moderate group, b P < 0.05.